How Real-World Data is Revolutionizing Rare Oncology Drug Development

Download “How Real-World Data is Revolutionizing Rare Oncology Drug Development”

Oncology experts met to discuss the unique challenges of drug development for rare diseases and how the use of RWD can help mitigate these problems and accelerate development of potentially life-saving therapies.

Access the full report of their roundtable meeting for insights into the challenges and benefits of using RWD for rare oncology disease drug development.

Discussion includes:

RWD’s role in the development and administration of precision medicine and other novel treatments

Challenges of RWD not being a “one size fits all” approach Importance of collaboration when accessing RWD Regulatory challenges

First Name

Last Name

Job Title

In which industry do you work?

Company Name

Address

City

State

Postal Code

Country

Phone

How many people are employed by your entire organization?

Company Revenue

By completing this form you agree CMIC Group and Informa Pharma Intelligence may contact you directly about industry news, products, services and events that may be of interest to you subject to their privacy policies. View the CMIC Group <a href="https://en.cmicgroup.com/about-cmic/privacy-policy/?elqTrackId=ba23bb6871dd4ba0b3c16578988bc757&elqa.">Privacy Policy</a> and the Informa Pharma Intelligence <a href="https://en.cmicgroup.com/about-cmic/privacy-policy/?elqTrackId=ba23bb6871dd4ba0b3c16578988bc757&elqa.">Privacy Policy</a>
Yes No

I consent to have this website store my submitted information so they can respond to my inquiry.See your Privacy Policy to learn more about how we use data.